Annual EBIT
-$223.05 M
-$450.12 M-198.23%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual earnings before interest & taxes is -$223.05 million, with the most recent change of -$450.12 million (-198.23%) on December 31, 2023.
- During the last 3 years, ABCL annual EBIT has fallen by -$387.40 million (-235.72%).
- ABCL annual EBIT is now -198.23% below its all-time high of $227.06 million, reached on December 31, 2022.
Performance
ABCL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$90.17 M
-$28.00 K-0.03%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly earnings before interest & taxes is -$90.17 million, with the most recent change of -$28.00 thousand (-0.03%) on September 30, 2024.
- Over the past year, ABCL quarterly EBIT has dropped by -$28.00 thousand (-0.03%).
- ABCL quarterly EBIT is now -139.18% below its all-time high of $230.14 million, reached on March 31, 2022.
Performance
ABCL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$294.61 M
-$38.11 M-14.86%
September 30, 2024
Summary
- As of February 7, 2025, ABCL TTM earnings before interest & taxes is -$294.61 million, with the most recent change of -$38.11 million (-14.86%) on September 30, 2024.
- Over the past year, ABCL TTM EBIT has dropped by -$38.11 million (-14.86%).
- ABCL TTM EBIT is now -184.17% below its all-time high of $350.03 million, reached on September 30, 2022.
Performance
ABCL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ABCL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -198.2% | -0.0% | -14.9% |
| 3 y3 years | -235.7% | -280.2% | -200.2% |
| 5 y5 years | -10000.0% | -5682.9% | -10000.0% |
ABCL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -198.2% | at low | -139.2% | at low | -184.2% | at low |
| 5 y | 5-year | -198.2% | at low | -139.2% | at low | -184.2% | at low |
| alltime | all time | -198.2% | at low | -139.2% | at low | -184.2% | at low |
AbCellera Biologics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$90.17 M(+0.0%) | -$294.61 M(+14.9%) |
| Jun 2024 | - | -$90.14 M(+74.6%) | -$256.50 M(+20.3%) |
| Mar 2024 | - | -$51.62 M(-17.6%) | -$213.17 M(-4.4%) |
| Dec 2023 | -$223.05 M(-198.2%) | -$62.68 M(+20.4%) | -$223.05 M(+13.5%) |
| Sep 2023 | - | -$52.06 M(+11.2%) | -$196.48 M(+88.0%) |
| Jun 2023 | - | -$46.81 M(-23.9%) | -$104.53 M(+61.9%) |
| Mar 2023 | - | -$61.50 M(+70.3%) | -$64.58 M(-128.4%) |
| Dec 2022 | $227.06 M | -$36.10 M(-190.5%) | $227.06 M(-35.1%) |
| Sep 2022 | - | $39.88 M(-681.3%) | $350.03 M(+22.2%) |
| Jun 2022 | - | -$6.86 M(-103.0%) | $286.43 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $230.14 M(+164.9%) | $290.91 M(+31.0%) |
| Dec 2021 | $221.90 M(+35.0%) | $86.86 M(-466.3%) | $221.98 M(-24.5%) |
| Sep 2021 | - | -$23.72 M(+893.5%) | $293.99 M(-7.3%) |
| Jun 2021 | - | -$2.39 M(-101.5%) | $317.27 M(-2.9%) |
| Mar 2021 | - | $161.22 M(+1.5%) | $326.66 M(+98.8%) |
| Dec 2020 | $164.34 M(-8309.0%) | $158.87 M(<-9900.0%) | $164.34 M(+4099.2%) |
| Sep 2020 | - | -$431.00 K(-106.2%) | $3.91 M(-9.9%) |
| Jun 2020 | - | $7.00 M(-740.7%) | $4.34 M(-263.9%) |
| Mar 2020 | - | -$1.09 M(-30.0%) | -$2.65 M(+70.0%) |
| Dec 2019 | -$2.00 M(-484.3%) | -$1.56 M | -$1.56 M |
| Dec 2018 | $521.00 K | - | - |
FAQ
- What is AbCellera Biologics annual earnings before interest & taxes?
- What is the all time high annual EBIT for AbCellera Biologics?
- What is AbCellera Biologics annual EBIT year-on-year change?
- What is AbCellera Biologics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AbCellera Biologics?
- What is AbCellera Biologics quarterly EBIT year-on-year change?
- What is AbCellera Biologics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AbCellera Biologics?
- What is AbCellera Biologics TTM EBIT year-on-year change?
What is AbCellera Biologics annual earnings before interest & taxes?
The current annual EBIT of ABCL is -$223.05 M
What is the all time high annual EBIT for AbCellera Biologics?
AbCellera Biologics all-time high annual earnings before interest & taxes is $227.06 M
What is AbCellera Biologics annual EBIT year-on-year change?
Over the past year, ABCL annual earnings before interest & taxes has changed by -$450.12 M (-198.23%)
What is AbCellera Biologics quarterly earnings before interest & taxes?
The current quarterly EBIT of ABCL is -$90.17 M
What is the all time high quarterly EBIT for AbCellera Biologics?
AbCellera Biologics all-time high quarterly earnings before interest & taxes is $230.14 M
What is AbCellera Biologics quarterly EBIT year-on-year change?
Over the past year, ABCL quarterly earnings before interest & taxes has changed by -$28.00 K (-0.03%)
What is AbCellera Biologics TTM earnings before interest & taxes?
The current TTM EBIT of ABCL is -$294.61 M
What is the all time high TTM EBIT for AbCellera Biologics?
AbCellera Biologics all-time high TTM earnings before interest & taxes is $350.03 M
What is AbCellera Biologics TTM EBIT year-on-year change?
Over the past year, ABCL TTM earnings before interest & taxes has changed by -$38.11 M (-14.86%)